Cupid Limited (CUPID.NS)
- Previous Close
77.51 - Open
76.30 - Bid --
- Ask --
- Day's Range
75.81 - 79.15 - 52 Week Range
55.75 - 109.00 - Volume
1,143,323 - Avg. Volume
1,563,563 - Market Cap (intraday)
21.018B - Beta (5Y Monthly) 0.17
- PE Ratio (TTM)
124.32 - EPS (TTM)
0.63 - Earnings Date Feb 14, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Sep 18, 2023
- 1y Target Est
--
Cupid Limited designs, manufactures, markets, and exports male and female condoms in India. The company offers water based lubricant jellies; in vitro diagnostic kits, including rapid diagnostic, viral transport medium, typhoid antibody, syphilis antibody, HIV 1 and 2 kit antibody, dengue IgG/IgM Antibody, malaria Pf-Pv and Pf-PAN antigen, hepatitis B (HbsAg) antigen, hepatitis C (HCV) antibody, pregnancy hCG detection, LH ovulation rapid, and dengue NS1 test; and deodorant and pocket perfumes. It also exports its products to countries in Africa, Europe, Ocenia, Asia, North America, and South America. The company was formerly known as Cupid Condom Limited and changed its name to Cupid Limited in January 2006. The company was incorporated in 1993 and is based in Nashik, India.
www.cupidlimited.com169
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: CUPID.NS
View MorePerformance Overview: CUPID.NS
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CUPID.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CUPID.NS
View MoreValuation Measures
Market Cap
21.01B
Enterprise Value
19.29B
Trailing P/E
122.95
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
112.83
Price/Book (mrq)
6.55
Enterprise Value/Revenue
10.35
Enterprise Value/EBITDA
25.38
Financial Highlights
Profitability and Income Statement
Profit Margin
27.93%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
1.9B
Net Income Avi to Common (ttm)
530.5M
Diluted EPS (ttm)
0.63
Balance Sheet and Cash Flow
Total Cash (mrq)
1.84B
Total Debt/Equity (mrq)
4.91%
Levered Free Cash Flow (ttm)
--